Search
Contineum Therapeutics Inc
CTNMAdd to Watchlist
15.100USD
-0.140-0.92%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
563.53MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-02 The current financial score of Contineum Therapeutics Inc is 8.66, ranking 35 out of 387 in the Biotechnology & Medical Research industry. Its financial status is robust, and its operating efficiency is high.
Financials
8.04
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.63
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.62
Free cash flow
Relevant data have not been disclosed by the company yet.